GSK has concluded the acquisition of efimosfermin alfa, an investigational therapeutic for serious liver disease, from Boston Pharmaceuticals ...

London: GSK plc has concluded the acquisition of efimosfermin alfa from Boston Pharmaceuticals in a USD 2 billion ...

GSK completes $2 billion acquisition of efimosfermin from Boston Pharmaceuticals: London, UK Wednesday, July 9, 2025, 09:00 Hrs [IST] GSK plc announced the completion of its previ ...

Cycle Pharmaceuticals announced the launch of HARLIKU, the first and only FDA-approved treatment for reducing urinary ...

Presentations highlight clinically meaningful reductions in BMI in patients with acquired hypothalamic obesity – - Full data ...

A Cambridge biotech company is preparing to lay off its entire staff of more than 300 after being acquired by another firm.

Abbott is doubling down on the structural heart space, as it aims to gain ground in valve replacements following the recent ...

HYDERABAD, India — (AP) — The death toll from Monday's massive explosion and fire at a pharmaceutical factory in India’s ...

Invagen Pharmaceuticals Inc. will add 70 medical manufacturing jobs with a state tax incentive program worth almost $1.8 million.

The Boston Arts Academy Foundation closed its Building Our Future fundraising campaign, surpassing its $35 million goal, thanks to twin $1 million donations – one from Vertex Pharmaceuticals ...

The project marks a significant step forward in addressing the critical need for purpose-built life sciences manufacturing ...